文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Rescuing natural killer cells from the cancer wilderness.

作者信息

Huntington Nicholas D

机构信息

BDI, Monash University, Melbourne, Victoria, Australia

出版信息

J Immunother Cancer. 2025 May 31;13(5):e011583. doi: 10.1136/jitc-2025-011583.

DOI:10.1136/jitc-2025-011583
PMID:40449957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12128426/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f808/12128426/69cc22a63bf9/jitc-13-5-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f808/12128426/69cc22a63bf9/jitc-13-5-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f808/12128426/69cc22a63bf9/jitc-13-5-g001.jpg

相似文献

[1]
Rescuing natural killer cells from the cancer wilderness.

J Immunother Cancer. 2025-5-31

[2]
Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer.

Biomolecules. 2023-2-10

[3]
NK and cells with NK-like activities in cancer immunotherapy-clinical perspectives.

Med Oncol. 2022-6-18

[4]
Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy.

Front Immunol. 2021

[5]
Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy.

Pharmacol Ther. 2022-7

[6]
Natural killer cells as a double-edged sword in cancer immunotherapy: A comprehensive review from cytokine therapy to adoptive cell immunotherapy.

Pharmacol Res. 2020-5

[7]
Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.

Front Immunol. 2021-1-29

[8]
Natural killer cells differentiated in vitro from cord blood CD34 cells are more advantageous for use as an immunotherapy than peripheral blood and cord blood natural killer cells.

Cytotherapy. 2017-6

[9]
Shaping of Natural Killer Cell Antitumor Activity by Cultivation.

Front Immunol. 2017-4-26

[10]
Natural Killer Cell Engagers (NKCEs): a new frontier in cancer immunotherapy.

Front Immunol. 2023

本文引用的文献

[1]
Tumor-induced natural killer cell dysfunction is a rapid and reversible process uncoupled from the expression of immune checkpoints.

Sci Adv. 2024-8-30

[2]
Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunity.

Nat Commun. 2024-1-24

[3]
IKAROS and AIOLOS directly regulate AP-1 transcriptional complexes and are essential for NK cell development.

Nat Immunol. 2024-2

[4]
Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer.

NPJ Precis Oncol. 2023-3-8

[5]
Immune dysregulation caused by homozygous mutations in CBLB.

J Clin Invest. 2022-10-17

[6]
RASA2 ablation in T cells boosts antigen sensitivity and long-term function.

Nature. 2022-9

[7]
Targeting WEE1/AKT Restores p53-Dependent Natural Killer-Cell Activation to Induce Immune Checkpoint Blockade Responses in "Cold" Melanoma.

Cancer Immunol Res. 2022-6-3

[8]
ablation with CRISPR/Cas9 enhances cytotoxicity of human placental stem cell-derived NK cells for cancer immunotherapy.

J Immunother Cancer. 2021-3

[9]
The cancer-natural killer cell immunity cycle.

Nat Rev Cancer. 2020-6-24

[10]
Cbl Ubiquitin Ligases Control B Cell Exit from the Germinal-Center Reaction.

Immunity. 2018-3-20

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索